UnknownNot Applicable

The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium

China96 participantsStarted 2019-10

Plain-language summary

The purpose of this study is to investigate the efficacy of the granulocyte-macrophage colony stimulating factor(GM-CSF) gel on the endometrial thickness in infertile women with thin endometrium.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Woman undergoes IVF treatment, 18-40 years old
✓. The endometrial thickness \<7mm on the day of human chorionic gonadotropin during IVF or after taking oral estradiol valerate 6mg/d for 14 days.
✓. Embryo transfer is cancelled because of thin endometrium
✓. No intrauterine adhesion according to the 3-D ultrasonography

Exclusion criteria

✕. Systemic diseases unable to conceive
✕. Chromasome abnormal
✕. History of G-CSF or GM-CSF allergy or untoward effect
✕. Thin endometrium related to clomid
✕. Severe or moderate uterine adhesion
✕. The influence factor of embryo implantation: hydrosalpinx, endometriosis, adenomyosis,myoma of uterus
✕. Uterine malformation, adenomyosis, uterine leiomyoma sized more than 2cm.
✕. Patients who is allergic to granulocyte-macrophage colony stimulating factor

What they're measuring

the endometrial thickness

Timeframe: 1 months after hysteroscopy examination

Trial details

NCT IDNCT04100655

SponsorSir Run Run Shaw Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06

Contact for this trial

Xiaona Lin, Doctor

+8657186006252 linna73@263.net

View on ClinicalTrials.gov More Thin Endometrium trials